{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:08:51Z","timestamp":1792757331883,"version":"4.5.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10787-023-01344-4","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T08:36:57Z","timestamp":1696840617000},"page":"3005-3020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies"],"prefix":"10.1007","volume":"31","author":[{"given":"Zahra","family":"Shafaghat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir-Hossein Khosrozadeh","family":"Ghomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0653-2724","authenticated-orcid":false,"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,8]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118097","volume":"257","author":"M Abbasifard","year":"2020","unstructured":"Abbasifard M, Khorramdelazad H (2020) The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics. Life Sci 257:118097","journal-title":"Life Sci"},{"key":"1344_CR2","doi-asserted-by":"crossref","unstructured":"Ahmadi P, Hartjen P, Kohsar M, Kummer S, Schmiedel S, Bockmann J-H, Fathi A, Huber S, Haag F, Schulze zur Wiesch J (2020) Defining the CD39\/CD73 axis in SARS-CoV-2 infection: the CD73-phenotype identifies polyfunctional cytotoxic lymphocytes. Cells 9(8): 1750","DOI":"10.3390\/cells9081750"},{"key":"1344_CR3","doi-asserted-by":"crossref","unstructured":"Ahmadi P, Hartjen P, Kohsar M, Kummer S, Schmiedel S, Bockmann JH, Fathi A, Huber S, Haag F, Schulze Zur Wiesch J (2020) Defining the CD39\/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes. Cells 9(8)","DOI":"10.3390\/cells9081750"},{"issue":"6","key":"1344_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.2174\/1381612826666201001125604","volume":"27","author":"KF Aliter","year":"2021","unstructured":"Aliter KF, Al-Horani RA (2021) Potential therapeutic benefits of dipyridamole in COVID-19 patients. Curr Pharm Des 27(6):866\u2013875","journal-title":"Curr Pharm Des"},{"issue":"4","key":"1344_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/s-0041-1726033","volume":"47","author":"A Allaoui","year":"2021","unstructured":"Allaoui A, Khawaja AA, Badad O, Naciri M, Lordkipanidz\u00e9 M, Guessous F, Zaid Y (2021) Platelet function in viral immunity and SARS-CoV-2 infection. Semin Thromb Hemost 47(4):419\u2013426","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"1344_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","volume":"17","author":"B Allard","year":"2020","unstructured":"Allard B, Allard D, Buisseret L, Stagg J (2020) The adenosine pathway in immuno-oncology. Nat Rev Clin Oncol 17(10):611\u2013629","journal-title":"Nat Rev Clin Oncol"},{"key":"1344_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.imlet.2018.05.001","volume":"205","author":"D Allard","year":"2019","unstructured":"Allard D, Chrobak P, Allard B, Messaoudi N, Stagg J (2019) Targeting the CD73-adenosine axis in immuno-oncology. Immunol Lett 205:31\u201339","journal-title":"Immunol Lett"},{"issue":"6","key":"1344_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli L, Pacher P, Vizi ES, Hask\u00f3 G (2013) CD39 and CD73 in immunity and inflammation. Trends Mol Med 19(6):355\u2013367","journal-title":"Trends Mol Med"},{"issue":"1","key":"1344_CR9","first-page":"175","volume":"34","author":"M Ayan","year":"2020","unstructured":"Ayan M, Kovelamudi S, Al-Hawwas M (2020) Subacute stent thrombosis in a patient with COVID-19 pneumonia. Proc (bayl Univ Med Cent) 34(1):175\u2013177","journal-title":"Proc (bayl Univ Med Cent)"},{"issue":"2","key":"1344_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.sbi.2013.04.005","volume":"23","author":"I Baconguis","year":"2013","unstructured":"Baconguis I, Hattori M, Gouaux E (2013) Unanticipated parallels in architecture and mechanism between ATP-gated P2X receptors and acid sensing ion channels. Curr Opin Struct Biol 23(2):277\u2013284","journal-title":"Curr Opin Struct Biol"},{"key":"1344_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.633603","volume":"12","author":"AMO Battastini","year":"2021","unstructured":"Battastini AMO, Figueir\u00f3 F, Leal DBR, Doleski PH, Schetinger MRC (2021) CD39 and CD73 as promising therapeutic targets: what could be the limitations? Front Pharmacol 12:633603","journal-title":"Front Pharmacol"},{"key":"1344_CR12","doi-asserted-by":"crossref","unstructured":"Bergamin LS, Braganhol E, Zanin RF, Edelweiss MIA, Battastini AMO (2012) \"Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview. Journal of Biomedicine and Biotechnology 2012.","DOI":"10.1155\/2012\/959848"},{"issue":"2","key":"1344_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7(2):99\u2013109","journal-title":"Nat Rev Microbiol"},{"key":"1344_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jama.290.2.238","volume":"290","author":"A Board","year":"2003","unstructured":"Board A, Bihari D (2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis. JAMA 290:238\u2013247","journal-title":"JAMA"},{"issue":"26","key":"1344_CR15","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.2174\/1381612825666190716111245","volume":"25","author":"P Borah","year":"2019","unstructured":"Borah P, Deka S, Mailavaram RP, Deb PK (2019) P1 receptor agonists\/antagonists in clinical trials-potential drug candidates of the future. Curr Pharm Des 25(26):2792\u20132807","journal-title":"Curr Pharm Des"},{"key":"1344_CR16","doi-asserted-by":"crossref","unstructured":"Borges do Nascimento IJ, Cacic N, Abdulazeem HM, Von Groote TC, Jayarajah U, Weerasekara I, Esfahani MA, Civile VT A. Marusic and A. Jeroncic (2020) Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis J Clin Med 9(4): 941","DOI":"10.3390\/jcm9040941"},{"issue":"4","key":"1344_CR17","first-page":"1225","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, H\u00f6pner S, Centonze D, Bernardi G, Dell\u2019Acqua ML (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood J Am Soc Hematol 110(4):1225\u20131232","journal-title":"Blood J Am Soc Hematol"},{"issue":"4","key":"1344_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/oxfordjournals.bja.a013473","volume":"84","author":"G Burnstock","year":"2000","unstructured":"Burnstock G (2000) P2X receptors in sensory neurones. Br J Anaesth 84(4):476\u2013488","journal-title":"Br J Anaesth"},{"key":"1344_CR19","doi-asserted-by":"crossref","unstructured":"Burnstock G (2006) Purinergic signalling\u2014an overview. Purinergic signalling in neuron\u2013glia interactions: novartis foundation symposium 276, Wiley Online Library.","DOI":"10.1002\/9780470032244.ch4"},{"key":"1344_CR20","doi-asserted-by":"publisher","first-page":"239821281881749","DOI":"10.1177\/2398212818817494","volume":"2","author":"G Burnstock","year":"2018","unstructured":"Burnstock G (2018) Purine and purinergic receptors. Brain Neurosci Adv 2:2398212818817494","journal-title":"Brain Neurosci Adv"},{"issue":"1","key":"1344_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jth.15566","volume":"20","author":"A Caillon","year":"2022","unstructured":"Caillon A, Trimaille A, Favre J, Jesel L, Morel O, Kauffenstein G (2022) Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy. J Thromb Haemost 20(1):17\u201331","journal-title":"J Thromb Haemost"},{"key":"1344_CR22","doi-asserted-by":"crossref","unstructured":"Campos-Contreras ADR, D\u00edaz-Mu\u00f1oz M, V\u00e1zquez-Cuevas FG (2020) Purinergic signaling in the hallmarks of cancer Cells 9(7)","DOI":"10.3390\/cells9071612"},{"key":"1344_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613070","volume":"12","author":"M Caracciolo","year":"2021","unstructured":"Caracciolo M, Correale P, Mangano C, Foti G, Falcone C, Macheda S, Cuzzola M, Conte M, Falzea AC, Iuliano E (2021) Efficacy and effect of inhaled adenosine treatment in hospitalized COVID-19 patients. Front Immunol 12:613070","journal-title":"Front Immunol"},{"issue":"3","key":"1344_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s11302-020-09713-2","volume":"16","author":"AM Cardoso","year":"2020","unstructured":"Cardoso AM (2020) COVID-19 and purinergic signaling: the need for investigation. Purinergic Signalling 16(3):451\u2013452","journal-title":"Purinergic Signalling"},{"key":"1344_CR25","doi-asserted-by":"crossref","unstructured":"Carotti V, Rigalli JP, van Asbeck-van der Wijst J, Hoenderop JG (2022) Interplay between purinergic signalling and extracellular vesicles in health and disease. Biochem Pharmacol 115192.","DOI":"10.1016\/j.bcp.2022.115192"},{"key":"1344_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fncel.2015.00211","volume":"9","author":"F Cavaliere","year":"2015","unstructured":"Cavaliere F, Donno C, D\u2019Ambrosi N (2015) Purinergic signaling: a common pathway for neural and mesenchymal stem cell maintenance and differentiation. Front Cell Neurosci 9:211","journal-title":"Front Cell Neurosci"},{"issue":"10\u201311","key":"1344_CR27","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.micinf.2009.05.001","volume":"11","author":"SP Chaves","year":"2009","unstructured":"Chaves SP, Torres-Santos EC, Marques C, Figliuolo VR, Persechini PM, Coutinho-Silva R, Rossi-Bergmann B (2009) Modulation of P2X7 purinergic receptor in macrophages by Leishmania amazonensis and its role in parasite elimination. Microbes Infect 11(10\u201311):842\u2013849","journal-title":"Microbes Infect"},{"issue":"4","key":"1344_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.21037\/cdt-20-485","volume":"10","author":"R Choudhary","year":"2020","unstructured":"Choudhary R, Kaushik A, Sharma JB (2020) COVID-19 pandemic and stent thrombosis in a post percutaneous coronary intervention patient-a case report highlighting the selection of P2Y12 inhibitor. Cardiovasc Diagnosis Therapy 10(4):898","journal-title":"Cardiovasc Diagnosis Therapy"},{"key":"1344_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11302-005-5302-5","volume":"2","author":"SP Colgan","year":"2006","unstructured":"Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5\u2019-nucleotidase (CD73). Purinergic Signal 2:351\u2013360","journal-title":"Purinergic Signal"},{"issue":"42","key":"1344_CR30","doi-asserted-by":"publisher","first-page":"28480","DOI":"10.1074\/jbc.M800039200","volume":"283","author":"R Corriden","year":"2008","unstructured":"Corriden R, Chen Y, Inoue Y, Beldi G, Robson SC, Insel PA, Junger WG (2008) Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1\/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. J Biol Chem 283(42):28480\u201328486","journal-title":"J Biol Chem"},{"key":"1344_CR31","doi-asserted-by":"crossref","unstructured":"Corriden R, Insel PA (2010) Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci Signal 3(104): re1-re1.","DOI":"10.1126\/scisignal.3104re1"},{"issue":"2","key":"1344_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116(2):205\u2013219","journal-title":"Cell"},{"key":"1344_CR33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3389\/fimmu.2019.00698","volume":"10","author":"S De Leve","year":"2019","unstructured":"De Leve S, Wirsd\u00f6rfer F, Jendrossek V (2019) Targeting the immunomodulatory CD73\/adenosine system to improve the therapeutic gain of radiotherapy. Front Immunol 10:698","journal-title":"Front Immunol"},{"issue":"3","key":"1344_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/onc.2016.206","volume":"36","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Adinolfi E (2017) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36(3):293\u2013303","journal-title":"Oncogene"},{"issue":"8","key":"1344_CR35","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1002\/jcp.30805","volume":"237","author":"GP Dorneles","year":"2022","unstructured":"Dorneles GP, Teixeira PC, da Silva IM, Schipper LL, Santana Filho PC, Rodrigues Junior LC, Bonorino C, Peres A, Fonseca SG, Monteiro MC (2022) Alterations in CD39\/CD73 axis of T cells associated with COVID-19 severity. J Cell Physiol 237(8):3394\u20133407","journal-title":"J Cell Physiol"},{"key":"1344_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuint.2014.03.014","volume":"73","author":"A dos Santos-Rodrigues","year":"2014","unstructured":"dos Santos-Rodrigues A, Gra\u00f1\u00e9-Boladeras N, Bicket A, Coe IR (2014) Nucleoside transporters in the purinome. Neurochem Int 73:229\u2013237","journal-title":"Neurochem Int"},{"key":"1344_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clim.2017.12.006","volume":"188","author":"L Dou","year":"2018","unstructured":"Dou L, Chen Y-F, Cowan PJ, Chen X-P (2018) Extracellular ATP signaling and clinical relevance. Clin Immunol 188:67\u201373","journal-title":"Clin Immunol"},{"issue":"6","key":"1344_CR38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/wdev.56","volume":"1","author":"L Erb","year":"2012","unstructured":"Erb L, Weisman GA (2012) Coupling of P2Y receptors to G proteins and other signaling pathways. Wiley Interdisciplinary Rev 1(6):789\u2013803","journal-title":"Wiley Interdisciplinary Rev"},{"issue":"6","key":"1344_CR39","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1017\/dmp.2020.156","volume":"14","author":"G Farnoosh","year":"2020","unstructured":"Farnoosh G, Ghanei M, Khorramdelazad H, Alishiri G, Farahani AJ, Shahriary A, Zijoud SRH (2020) Are Iranian sulfur mustard gas-exposed survivors more vulnerable to SARS-CoV-2? Some similarity in their pathogenesis. Disaster Med Public Health Prep 14(6):826\u2013832","journal-title":"Disaster Med Public Health Prep"},{"issue":"6","key":"1344_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.it.2016.04.004","volume":"37","author":"D Ferrari","year":"2016","unstructured":"Ferrari D, McNamee EN, Idzko M, Gambari R, Eltzschig HK (2016) Purinergic signaling during immune cell trafficking. Trends Immunol 37(6):399\u2013411","journal-title":"Trends Immunol"},{"key":"1344_CR41","doi-asserted-by":"crossref","unstructured":"Ferrari D, Rubini M, Burns JS (2022) The Potential of Purinergic Signaling to Fight Viruses including SARS-CoV-2. Front Immunol: 2663.","DOI":"10.3389\/fimmu.2022.904419"},{"issue":"12","key":"1344_CR42","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0166-2236(00)01674-X","volume":"23","author":"RD Fields","year":"2000","unstructured":"Fields RD, Stevens B (2000) ATP: an extracellular signaling molecule between neurons and glia. Trends Neurosci 23(12):625\u2013633","journal-title":"Trends Neurosci"},{"key":"1344_CR43","first-page":"93","volume-title":"Purinergic neurotransmission and nucleotide receptors","author":"SJ Fountain","year":"2023","unstructured":"Fountain SJ (2023) Purinergic neurotransmission and nucleotide receptors. Elsevier, Primer on the Autonomic Nervous System, pp 93\u201397"},{"issue":"8","key":"1344_CR44","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1007\/s11010-021-04130-4","volume":"476","author":"MLM Franciosi","year":"2021","unstructured":"Franciosi MLM, Lima MDM, Schetinger MRC, Cardoso AM (2021) Possible role of purinergic signaling in COVID-19. Mol Cell Biochem 476(8):2891\u20132898","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"1344_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0006-2952(00)00570-0","volume":"61","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, Irenius E, Kull B, Schulte G (2001) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61(4):443\u2013448","journal-title":"Biochem Pharmacol"},{"issue":"04","key":"1344_CR46","doi-asserted-by":"publisher","first-page":"e400","DOI":"10.1055\/s-0040-1721501","volume":"4","author":"MC Frise","year":"2020","unstructured":"Frise MC, Gates RE, Curry NS, Danbury CM (2020) Successful use of argatroban to treat a critically Ill patient with coagulopathy and nephropathy secondary to COVID-19. TH Open 4(04):e400\u2013e402","journal-title":"TH Open"},{"key":"1344_CR47","doi-asserted-by":"crossref","unstructured":"Furusato B, Rhim JS (2009) CXCR4 and cancer. Chemokine Receptors in Cancer: 31\u201345.","DOI":"10.1007\/978-1-60327-267-4_2"},{"key":"1344_CR48","doi-asserted-by":"crossref","unstructured":"Gando S, Wada T (2021) Thromboplasminflammation in COVID-19 coagulopathy: three viewpoints for diagnostic and therapeutic strategies. Front Immunol: 2292.","DOI":"10.3389\/fimmu.2021.649122"},{"key":"1344_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.894470","volume":"13","author":"J Garc\u00eda-Villalba","year":"2022","unstructured":"Garc\u00eda-Villalba J, Hurtado-Navarro L, Pe\u00f1\u00edn-Franch A, Molina-L\u00f3pez C, Mart\u00ednez-Alarc\u00f3n L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P (2022) Soluble P2X7 receptor is elevated in the plasma of COVID-19 patients and correlates with disease severity. Front Immunol 13:894470","journal-title":"Front Immunol"},{"key":"1344_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.594487","volume":"11","author":"JD Geiger","year":"2020","unstructured":"Geiger JD, Khan N, Murugan M, Boison D (2020) Possible role of adenosine in COVID-19 pathogenesis and therapeutic opportunities. Front Pharmacol 11:594487","journal-title":"Front Pharmacol"},{"key":"1344_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11302-006-9042-y","volume":"3","author":"S Gessi","year":"2007","unstructured":"Gessi S, Varani K, Merighi S, Fogli E, Sacchetto V, Benini A, Leung E, Mac-Lennan S, Borea PA (2007) Adenosine and lymphocyte regulation. Purinergic Signalling 3:109\u2013116","journal-title":"Purinergic Signalling"},{"issue":"2","key":"1344_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/14728222.2019.1559829","volume":"23","author":"G Ghalamfarsa","year":"2019","unstructured":"Ghalamfarsa G, Kazemi MH, Raoofi Mohseni S, Masjedi A, Hojjat-Farsangi M, Azizi G, Yousefi M, Jadidi-Niaragh F (2019) CD73 as a potential opportunity for cancer immunotherapy. Expert Opin Ther Targets 23(2):127\u2013142","journal-title":"Expert Opin Ther Targets"},{"key":"1344_CR53","doi-asserted-by":"crossref","unstructured":"Ghiringhelli F, Bruchard M, Chalmin F, R\u00e9b\u00e9 C (2012) Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape. J Biomed Biotechnol 2012","DOI":"10.1155\/2012\/473712"},{"issue":"5684","key":"1344_CR54","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.1099320","volume":"305","author":"DR Green","year":"2004","unstructured":"Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305(5684):626\u2013629","journal-title":"Science"},{"issue":"2\u20133","key":"1344_CR55","first-page":"236","volume":"151","author":"N Gupta","year":"2020","unstructured":"Gupta N, Praharaj I, Bhatnagar T, Thangaraj JWV, Giri S, Chauhan H, Kulkarni S, Murhekar M, Singh S, Gangakhedkar RR (2020) Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020. Indian J Med Res 151(2\u20133):236","journal-title":"Indian J Med Res"},{"issue":"9","key":"1344_CR56","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.4049\/jimmunol.2001342","volume":"206","author":"CB Haas","year":"2021","unstructured":"Haas CB, Lov\u00e1szi M, Braganhol E, Pacher P, Hask\u00f3 G (2021) Ectonucleotidases in inflammation, immunity, and cancer. J Immunol 206(9):1983\u20131990","journal-title":"J Immunol"},{"issue":"1","key":"1344_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1152\/physiol.00010.2021","volume":"37","author":"K Halpin-Veszeleiova","year":"2022","unstructured":"Halpin-Veszeleiova K, Hatfield SM (2022) Therapeutic targeting of Hypoxia-A2-adenosinergic pathway in COVID-19 patients. Physiology 37(1):46\u201352","journal-title":"Physiology"},{"key":"1344_CR58","doi-asserted-by":"crossref","unstructured":"Hashemi A, Madhavan MV, Bikdeli B (2020) Pharmacotherapy for prevention and management of thrombosis in COVID-19. Seminars in thrombosis and hemostasis, Thieme Medical Publishers.","DOI":"10.1055\/s-0040-1714273"},{"issue":"6","key":"1344_CR59","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1523\/JNEUROSCI.21-06-01975.2001","volume":"21","author":"S Honda","year":"2001","unstructured":"Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, Inoue K, Kohsaka S (2001) Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi\/o-coupled P2Y receptors. J Neurosci 21(6):1975\u20131982","journal-title":"J Neurosci"},{"issue":"1","key":"1344_CR60","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6(1):162","journal-title":"Signal Transduct Target Ther"},{"issue":"26","key":"1344_CR61","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.2174\/1381612825666190716112319","volume":"25","author":"S Jamwal","year":"2019","unstructured":"Jamwal S, Mittal A, Kumar P, Alhayani DM, Al-Aboudi A (2019) Therapeutic potential of agonists and antagonists of A1, A2a, A2b and A3 adenosine receptors. Curr Pharm Des 25(26):2892\u20132905","journal-title":"Curr Pharm Des"},{"issue":"22","key":"1344_CR62","doi-asserted-by":"publisher","first-page":"13444","DOI":"10.1021\/acs.jmedchem.0c01044","volume":"63","author":"JL Jeffrey","year":"2020","unstructured":"Jeffrey JL, Lawson KV, Powers JP (2020a) Targeting metabolism of extracellular nucleotides via Inhibition of ectonucleotidases CD73 and CD39. J Med Chem 63(22):13444\u201313465","journal-title":"J Med Chem"},{"issue":"40","key":"1344_CR63","doi-asserted-by":"publisher","first-page":"31199","DOI":"10.1074\/jbc.C000405200","volume":"275","author":"X Jiang","year":"2000","unstructured":"Jiang X, Wang X (2000) Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 275(40):31199\u201331203","journal-title":"J Biol Chem"},{"key":"1344_CR64","doi-asserted-by":"crossref","unstructured":"Kadenbach B, Arnold S, Lee I, H\u00fcttemann M (2004) The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1655: 400\u2013408.","DOI":"10.1016\/j.bbabio.2003.06.005"},{"key":"1344_CR65","doi-asserted-by":"crossref","unstructured":"Kanthi Y, Knight JS, Zuo Y, Pinsky DJ (2020) New (re) purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm. JCI insight 5(14).","DOI":"10.1172\/jci.insight.140971"},{"issue":"1","key":"1344_CR66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/imr.12571","volume":"280","author":"O Kepp","year":"2017","unstructured":"Kepp O, Loos F, Liu P, Kroemer G (2017) Extracellular nucleosides and nucleotides as immunomodulators. Immunol Rev 280(1):83\u201392","journal-title":"Immunol Rev"},{"key":"1344_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104554","volume":"152","author":"H Khorramdelazad","year":"2021","unstructured":"Khorramdelazad H, Kazemi MH, Najafi A, Keykhaee M, Emameh RZ, Falak R (2021) Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microb Pathog 152:104554","journal-title":"Microb Pathog"},{"issue":"2","key":"1344_CR68","first-page":"11","volume":"70","author":"D Kumar","year":"2022","unstructured":"Kumar D, Kaimaparambil V, Chandralekha S, Lalchandani J (2022) Oral rivaroxaban in the prophylaxis of COVID-19 induced coagulopathy. J Assoc Physicians India 70(2):11\u201312","journal-title":"J Assoc Physicians India"},{"issue":"5","key":"1344_CR69","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.clinthera.2016.04.002","volume":"38","author":"C Ledderose","year":"2016","unstructured":"Ledderose C, Bao Y, Kondo Y, Fakhari M, Slubowski C, Zhang J, Junger WG (2016) Purinergic signaling and the immune response in sepsis: a review. Clin Ther 38(5):1054\u20131065","journal-title":"Clin Ther"},{"key":"1344_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.626484","volume":"11","author":"R Leite-Aguiar","year":"2021","unstructured":"Leite-Aguiar R, Alves VS, Savio LEB, Coutinho-Silva R (2021) Targeting purinergic signaling in the dynamics of disease progression in sepsis. Front Pharmacol 11:626484","journal-title":"Front Pharmacol"},{"issue":"12","key":"1344_CR71","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1097\/QAD.0000000000003314","volume":"36","author":"G Li","year":"2022","unstructured":"Li G, Park LS, Lodi S, Logan RW, Cartwright EJ, Aoun-Barakat L, Casas JP, Dickerman BA, Rentsch CT, Justice AC (2022) Tenofovir disoproxil fumarate and coronavirus disease 2019 outcomes in men with HIV. AIDS 36(12):1689\u20131696","journal-title":"AIDS"},{"issue":"10","key":"1344_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076731","volume":"8","author":"S Li","year":"2013","unstructured":"Li S, Li X, Guo H, Liu S, Huang H, Liu N, Yang C, Tang P, Liu J (2013) Intracellular ATP concentration contributes to the cytotoxic and cytoprotective effects of adenosine. PLoS ONE 8(10):e76731","journal-title":"PLoS ONE"},{"key":"1344_CR73","doi-asserted-by":"crossref","unstructured":"Linnemann C, Schildberg FA, Schurich A, Diehl L, Hegenbarth SI, Endl E, Lacher S, M\u00fcller CE, Frey J, Simeoni L (2009) Adenosine regulates CD8 T\u2010cell priming by inhibition of membrane\u2010proximal T\u2010cell receptor signalling. Immunology 128(1pt2): e728-e737","DOI":"10.1111\/j.1365-2567.2009.03075.x"},{"issue":"4","key":"1344_CR74","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/med.21888","volume":"42","author":"A Mahmood","year":"2022","unstructured":"Mahmood A, Iqbal J (2022) Purinergic receptors modulators: an emerging pharmacological tool for disease management. Med Res Rev 42(4):1661\u20131703","journal-title":"Med Res Rev"},{"key":"1344_CR75","doi-asserted-by":"crossref","unstructured":"Mazzeffi M, Chow JH, Amoroso A, Tanaka K (2020) Revisiting the protein C pathway: an opportunity for adjunctive intervention in COVID-19? Anesthesia and Analgesia","DOI":"10.1213\/ANE.0000000000005059"},{"issue":"12","key":"1344_CR76","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S2213-2600(22)00404-0","volume":"10","author":"SB Mazzone","year":"2022","unstructured":"Mazzone SB, Satia I, McGarvey L, Song W-J, Chung KF (2022) Chronic cough and cough hypersensitivity: from mechanistic insights to novel antitussives. Lancet Respir Med 10(12):1113\u20131115","journal-title":"Lancet Respir Med"},{"key":"1344_CR77","doi-asserted-by":"crossref","unstructured":"Miller RA, Guru P, Bauer P, Robles J, Tomaszewski C, Overcash JS, Waters M, Cameron M, Olalla Sierra J, Mashhedi H (2021) Clinical results with a B cell activating Anti-CD73 antibody for the immunotherapy of COVID-19. MedRxiv: 2021.2009. 2013.21263406","DOI":"10.1101\/2021.09.13.21263406"},{"issue":"12","key":"1344_CR78","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41577-020-0376-4","volume":"20","author":"AK Moesta","year":"2020","unstructured":"Moesta AK, Li X-Y, Smyth MJ (2020) Targeting CD39 in cancer. Nat Rev Immunol 20(12):739\u2013755","journal-title":"Nat Rev Immunol"},{"key":"1344_CR79","doi-asserted-by":"crossref","unstructured":"Morello S, Caiazzo E, Turiello R, Cicala C (2021) Thrombo-Inflammation: A Focus on NTPDase1\/CD39. Cells 10(9)","DOI":"10.3390\/cells10092223"},{"issue":"9","key":"1344_CR80","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.3390\/cells10092223","volume":"10","author":"S Morello","year":"2021","unstructured":"Morello S, Caiazzo E, Turiello R, Cicala C (2021b) Thrombo-inflammation: a focus on NTPDase1\/CD39. Cells 10(9):2223","journal-title":"Cells"},{"key":"1344_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120482","volume":"297","author":"Z Nadeali","year":"2022","unstructured":"Nadeali Z, Mohammad-Rezaei F, Aria H, Nikpour P (2022a) Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19. Life Sci 297:120482","journal-title":"Life Sci"},{"issue":"10","key":"1344_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267423","volume":"17","author":"H Nakhaee","year":"2022","unstructured":"Nakhaee H, Zangiabadian M, Bayati R, Rahmanian M, Ghaffari Jolfayi A, Rakhshanderou S (2022) The effect of antidepressants on the severity of COVID-19 in hospitalized patients: a systematic review and meta-analysis. PLoS ONE 17(10):e0267423","journal-title":"PLoS ONE"},{"issue":"3","key":"1344_CR83","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1172\/JCI128895","volume":"130","author":"SY Neo","year":"2020","unstructured":"Neo SY, Yang Y, Record J, Ma R, Chen X, Chen Z, Tobin NP, Blake E, Seitz C, Thomas R (2020) CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment. J Clin Investig 130(3):1185\u20131198","journal-title":"J Clin Investig"},{"key":"1344_CR84","doi-asserted-by":"crossref","unstructured":"Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N (2013) Crosstalk between apoptosis, necrosis and autophagy. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833(12): 3448\u20133459.","DOI":"10.1016\/j.bbamcr.2013.06.001"},{"issue":"1700","key":"1344_CR85","doi-asserted-by":"publisher","first-page":"20150427","DOI":"10.1098\/rstb.2015.0427","volume":"371","author":"RA North","year":"2016","unstructured":"North RA (2016) P2X receptors. PhilosophTrans R Soc b 371(1700):20150427","journal-title":"PhilosophTrans R Soc b"},{"issue":"20","key":"1344_CR86","doi-asserted-by":"publisher","first-page":"7636","DOI":"10.3390\/ijms21207636","volume":"21","author":"B Opdebeeck","year":"2020","unstructured":"Opdebeeck B, Orriss IR, Neven E, D\u2019Haese PC, Verhulst A (2020) Extracellular nucleotides regulate arterial calcification by activating both independent and dependent purinergic receptor signaling pathways. Int J Mol Sci 21(20):7636","journal-title":"Int J Mol Sci"},{"issue":"14","key":"1344_CR87","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.micinf.2012.05.010","volume":"14","author":"A Paoletti","year":"2012","unstructured":"Paoletti A, Raza SQ, Voisin L, Law F, da Fonseca JP, Caillet M, Kroemer G, Perfettini J-L (2012) Multifaceted roles of purinergic receptors in viral infection. Microbes Infect 14(14):1278\u20131283","journal-title":"Microbes Infect"},{"issue":"3","key":"1344_CR88","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5501\/wjv.v4.i3.285","volume":"4","author":"DF Passos","year":"2015","unstructured":"Passos DF, Schetinger MRC, Leal DB (2015) Purinergic signaling and human immunodeficiency virus\/acquired immune deficiency syndrome: from viral entry to therapy. World J Virol 4(3):285","journal-title":"World J Virol"},{"key":"1344_CR89","doi-asserted-by":"crossref","unstructured":"Perrot I, Michaud H-A, Giraudon-Paoli M, Augier S, Docquier A, Gros L, Courtois R, Dejou C, Jecko D, Becquart O (2019) Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies. Cell Rep 27(8): 2411\u20132425. e2419","DOI":"10.1016\/j.celrep.2019.04.091"},{"issue":"1","key":"1344_CR90","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/apha.12402","volume":"213","author":"MM Rabadi","year":"2015","unstructured":"Rabadi MM, Lee HT (2015) Adenosine receptors and renal ischaemia reperfusion injury. Acta Physiol 213(1):222\u2013231","journal-title":"Acta Physiol"},{"issue":"3","key":"1344_CR91","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1021\/acsomega.1c05998","volume":"7","author":"AM Rabie","year":"2022","unstructured":"Rabie AM (2022) Potent inhibitory activities of the adenosine analogue cordycepin on SARS-CoV-2 replication. ACS Omega 7(3):2960\u20132969","journal-title":"ACS Omega"},{"key":"1344_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109325","volume":"113","author":"M Ranjbar","year":"2022","unstructured":"Ranjbar M, Rahimi A, Baghernejadan Z, Ghorbani A, Khorramdelazad H (2022) Role of CCL2\/CCR2 axis in the pathogenesis of COVID-19 and possible treatments: all options on the Table. Int Immunopharmacol 113:109325","journal-title":"Int Immunopharmacol"},{"key":"1344_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111273","volume":"137","author":"KP Reichert","year":"2021","unstructured":"Reichert KP, Castro MFV, Assmann CE, Bottari NB, Miron VV, Cardoso A, Stefanello N, Morsch VMM, Schetinger MRC (2021) Diabetes and hypertension: pivotal involvement of purinergic signaling. Biomed Pharmacother 137:111273","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"1344_CR94","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.4049\/jimmunol.1401434","volume":"194","author":"S Ring","year":"2015","unstructured":"Ring S, Pushkarevskaya A, Schild H, Probst HC, Jendrossek V, Wirsd\u00f6rfer F, Ledent C, Robson SC, Enk AH, Mahnke K (2015) Regulatory T cell\u2013derived adenosine induces dendritic cell migration through the Epac-Rap1 pathway. J Immunol 194(8):3735\u20133744","journal-title":"J Immunol"},{"issue":"6","key":"1344_CR95","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3390\/molecules27061913","volume":"27","author":"M Rossato","year":"2022","unstructured":"Rossato M, Favaretto F, Granzotto M, Crescenzi M, Boscaro A, Di Vincenzo A, Capone F, Dalla Nora E, Zabeo E, Vettor R (2022) Molecular and pharmacological evidence for the expression of multiple functional P2 purinergic receptors in human adipocytes. Molecules 27(6):1913","journal-title":"Molecules"},{"key":"1344_CR96","doi-asserted-by":"crossref","unstructured":"Schenk U, Frascoli M, Proietti M, Geffers R, Traggiai E, Buer J, Ricordi C, Westendorf AM, Grassi F (2011) ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal 4(162): ra12\u2013ra12","DOI":"10.1126\/scisignal.2001270"},{"key":"1344_CR97","doi-asserted-by":"crossref","unstructured":"Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Fumagalli M, Verderio C, Buer J, Scanziani E, Grassi F (2008) Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 1(39): ra6-ra6","DOI":"10.1126\/scisignal.1160583"},{"issue":"4","key":"1344_CR98","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4049\/jimmunol.2100446","volume":"207","author":"S Shahbaz","year":"2021","unstructured":"Shahbaz S, Xu L, Sligl W, Osman M, Bozorgmehr N, Mashhouri S, Redmond D, Perez Rosero E, Walker J, Elahi S (2021a) The quality of SARS-CoV-2-specific t cell functions differs in patients with mild\/moderate versus severe disease, and t cells expressing coinhibitory receptors are highly activated. J Immunol 207(4):1099\u20131111","journal-title":"J Immunol"},{"issue":"4","key":"1344_CR99","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4049\/jimmunol.2100446","volume":"207","author":"S Shahbaz","year":"2021","unstructured":"Shahbaz S, Xu L, Sligl W, Osman M, Bozorgmehr N, Mashhouri S, Redmond D, Perez Rosero E, Walker J, Elahi S (2021b) The quality of SARS-CoV-2\u2013specific T cell functions differs in patients with mild\/moderate versus severe disease, and T cells expressing coinhibitory receptors are highly activated. J Immunol 207(4):1099\u20131111","journal-title":"J Immunol"},{"key":"1344_CR100","doi-asserted-by":"crossref","unstructured":"Shi H, Dai H, Sun Q, Wang S, Chen Y (2023) CD73, a significant protein in liver diseases. Front Med 10","DOI":"10.3389\/fmed.2023.1147782"},{"issue":"4","key":"1344_CR101","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1007\/s10753-022-01656-7","volume":"45","author":"P Shivshankar","year":"2022","unstructured":"Shivshankar P, Karmouty-Quintana H, Mills T, Doursout M-F, Wang Y, Czopik AK, Evans SE, Eltzschig HK, Yuan X (2022) SARS-CoV-2 infection: host response, immunity, and therapeutic targets. Inflammation 45(4):1430\u20131449","journal-title":"Inflammation"},{"key":"1344_CR102","doi-asserted-by":"crossref","unstructured":"Sim\u00f5es JLB, Galvan ACL, da Silva ELM, Ign\u00e1cio ZM, Bagatini MD (2022) Therapeutic potential of the purinergic system in major depressive disorder associated with COVID-19. Cell Mol Neurobiol: 1\u201317.","DOI":"10.1007\/s10571-022-01215-6"},{"issue":"21","key":"1344_CR103","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1111\/bph.15194","volume":"177","author":"K Sriram","year":"2020","unstructured":"Sriram K, Insel PA (2020) Proteinase-activated receptor 1: a target for repurposing in the treatment of COVID-19? Br J Pharmacol 177(21):4971\u20134974","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1344_CR104","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1152\/physrev.00035.2020","volume":"101","author":"K Sriram","year":"2021","unstructured":"Sriram K, Insel PA (2021) Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets. Physiol Rev 101(2):545\u2013567","journal-title":"Physiol Rev"},{"issue":"1","key":"1344_CR105","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jphs.2019.09.006","volume":"141","author":"C Sun","year":"2019","unstructured":"Sun C, Jiao T, Merkus D, Duncker DJ, Mustafa SJ, Zhou Z (2019) Activation of adenosine A2A but not A2B receptors is involved in uridine adenosine tetraphosphate-induced porcine coronary smooth muscle relaxation. J Pharmacol Sci 141(1):64\u201369","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"1344_CR106","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2010.05.007","volume":"139","author":"X Sun","year":"2010","unstructured":"Sun X, Wu Y, Gao W, Enjyoji K, Csizmadia E, M\u00fcller CE, Murakami T, Robson SC (2010) CD39\/ENTPD1 expression by CD4+ Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 139(3):1030\u20131040","journal-title":"Gastroenterology"},{"issue":"3","key":"1344_CR107","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1158\/2326-6066.CIR-15-0050","volume":"4","author":"P Sundstr\u00f6m","year":"2016","unstructured":"Sundstr\u00f6m P, Stenstad H, Langenes V, Ahlmanner F, Theander L, Ndah TG, Fredin K, B\u00f6rjesson L, Gustavsson B, Bastid J (2016) Regulatory T cells from colon cancer patients inhibit effector T-cell migration through an adenosine-dependent mechanismtreg mediated inhibition of T-cell migration in cancer patients. Cancer Immunol Res 4(3):183\u2013193","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"1344_CR108","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/0166-2236(95)93907-F","volume":"18","author":"A Surprenant","year":"1995","unstructured":"Surprenant A, Buell G, North RA (1995) P2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci 18(5):224\u2013229","journal-title":"Trends Neurosci"},{"issue":"7","key":"1344_CR109","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.it.2016.04.009","volume":"37","author":"MC Takenaka","year":"2016","unstructured":"Takenaka MC, Robson S, Quintana FJ (2016) Regulation of the T cell response by CD39. Trends Immunol 37(7):427\u2013439","journal-title":"Trends Immunol"},{"issue":"1","key":"1344_CR110","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s41467-019-08801-1","volume":"10","author":"V Tardif","year":"2019","unstructured":"Tardif V, Muir R, Cubas R, Chakhtoura M, Wilkinson P, Metcalf T, Herro R, Haddad EK (2019) Adenosine deaminase-1 delineates human follicular helper T cell function and is altered with HIV. Nat Commun 10(1):823","journal-title":"Nat Commun"},{"issue":"3","key":"1344_CR111","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/25785826.2022.2079369","volume":"45","author":"M Tokano","year":"2022","unstructured":"Tokano M, Takagi R, Kawano M, Maesaki S, Tarumoto N, Matsushita S (2022) Signaling via dopamine and adenosine receptors modulate viral peptide-specific and T-cell IL-8 response in COVID-19. Immunological Medicine 45(3):162\u2013167","journal-title":"Immunological Medicine"},{"issue":"9","key":"1344_CR112","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3390\/jcm11092615","volume":"11","author":"CJ Toro-Huamanchumo","year":"2022","unstructured":"Toro-Huamanchumo CJ, Benites-Meza JK, Mamani-Garc\u00eda CS, Bustamante-Paytan D, Gracia-Ramos AE, Diaz-V\u00e9lez C, Barboza JJ (2022) Efficacy of colchicine in the treatment of COVID-19 patients: a systematic review and meta-analysis. J Clin Med 11(9):2615","journal-title":"J Clin Med"},{"issue":"12","key":"1344_CR113","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13871","volume":"52","author":"A Verma","year":"2022","unstructured":"Verma A, Ramayya T, Upadhyaya A, Valenta I, Lyons M, Marschall J, Dehdashti F, Gropler RJ, Woodard PK, Schindler TH (2022) Post COVID-19 syndrome with impairment of flow-mediated epicardial vasodilation and flow reserve. Eur J Clin Invest 52(12):e13871","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"1344_CR114","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan D, Young A, Teng MW, Smyth MJ (2017) Targeting immunosuppressive adenosine in cancer. Nat Rev Cancer 17(12):709\u2013724","journal-title":"Nat Rev Cancer"},{"key":"1344_CR115","doi-asserted-by":"crossref","unstructured":"Vultaggio-Poma V, Falzoni S, Salvi G, Giuliani AL, Di Virgilio F (2022) Signalling by extracellular nucleotides in health and disease. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research: 119237.","DOI":"10.1016\/j.bbamcr.2022.119237"},{"issue":"11","key":"1344_CR116","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3390\/cells9112496","volume":"9","author":"V Vultaggio-Poma","year":"2020","unstructured":"Vultaggio-Poma V, Sarti AC, Di Virgilio F (2020) Extracellular ATP: a feasible target for cancer therapy. Cells 9(11):2496","journal-title":"Cells"},{"key":"1344_CR117","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fimmu.2018.00399","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Chen D (2018) Purinergic regulation of neutrophil function. Front Immunol 9:399","journal-title":"Front Immunol"},{"issue":"1","key":"1344_CR118","doi-asserted-by":"publisher","first-page":"H90","DOI":"10.1152\/ajpheart.00570.2020","volume":"320","author":"B Wernly","year":"2021","unstructured":"Wernly B, Erlinge D, Pernow J, Zhou Z (2021) Ticagrelor: a cardiometabolic drug targeting erythrocyte-mediated purinergic signaling? Am J Physiol-Heart Circ Physiol 320(1):H90\u2013H94","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"18","key":"1344_CR119","first-page":"3475","volume":"116","author":"T Woehrle","year":"2010","unstructured":"Woehrle T, Yip L, Elkhal A, Sumi Y, Chen Y, Yao Y, Insel PA, Junger WG (2010) Pannexin-1 hemichannel\u2013mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood J Am Soc Hematol 116(18):3475\u20133484","journal-title":"Blood J Am Soc Hematol"},{"key":"1344_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114406","volume":"187","author":"LT Woods","year":"2021","unstructured":"Woods LT, Forti KM, Shanbhag VC, Camden JM, Weisman GA (2021) P2Y receptors for extracellular nucleotides: contributions to cancer progression and therapeutic implications. Biochem Pharmacol 187:114406","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1344_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KK, Fu L (2023) CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol Cancer 22(1):1\u201317","journal-title":"Mol Cancer"},{"issue":"6","key":"1344_CR122","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/10409238.2014.953627","volume":"49","author":"GG Yegutkin","year":"2014","unstructured":"Yegutkin GG (2014) Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities. Crit Rev Biochem Mol Biol 49(6):473\u2013497","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"3","key":"1344_CR123","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1124\/pharmrev.121.000528","volume":"74","author":"GG Yegutkin","year":"2022","unstructured":"Yegutkin GG, Boison D (2022) ATP and adenosine metabolism in cancer: exploitation for therapeutic gain. Pharmacol Rev 74(3):797\u2013822","journal-title":"Pharmacol Rev"},{"issue":"13","key":"1344_CR124","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.1073\/pnas.121587098","volume":"98","author":"K Yoshioka","year":"2001","unstructured":"Yoshioka K, Saitoh O, Nakata H (2001) Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci 98(13):7617\u20137622","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"1344_CR125","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/08923973.2021.1988102","volume":"43","author":"M Zarei","year":"2021","unstructured":"Zarei M, Sahebi Vaighan N, Ziai SA (2021a) Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19. Immunopharmacol Immunotoxicol 43(6):633\u2013643","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1344_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107055","volume":"89","author":"J Zeng","year":"2020","unstructured":"Zeng J, Ning Z, Wang Y, Xiong H (2020) Implications of CD39 in immune-related diseases. Int Immunopharmacol 89:107055","journal-title":"Int Immunopharmacol"},{"key":"1344_CR127","doi-asserted-by":"crossref","unstructured":"Zhong T, Huang Z, Pang X, Chen N, Kwek K, Wynne C, Konpa A, Jin X, Xia Y, Wang MZ (2020) 476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19, BMJ Specialist Journals.","DOI":"10.1136\/jitc-2020-SITC2020.0476"},{"issue":"1","key":"1344_CR128","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11302-015-9483-2","volume":"12","author":"H Zimmermann","year":"2016","unstructured":"Zimmermann H (2016) Extracellular ATP and other nucleotides\u2014ubiquitous triggers of intercellular messenger release. Purinergic Signalling 12(1):25\u201357","journal-title":"Purinergic Signalling"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01344-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T02:08:35Z","timestamp":1701482915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01344-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,8]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01344-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,8]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}